Palantir Continues Vital NHS Work with Two Year Contract
December 23 2020 - 6:32AM
Business Wire
Palantir Technologies, Inc (NYSE: PLTR) has signed a new
two-year contract with the UK National Health Service (NHS England
and NHS Improvement).
Palantir Foundry will provide the NHS with a software platform
for the secure, reliable, and timely processing of data – while
protecting the privacy of patients – to enable NHS decision makers
to best plan use of resources and improve patient care.
NHS personnel will use Palantir Foundry to:
- Understand how COVID-19 is spreading and identify risks to
particularly vulnerable populations.
- Proactively increase health and care resources in emerging hot
spots.
- Ensure critical equipment is supplied to the facilities with
the greatest need.
- Divert patients and service users to the facilities that are
best able to care for them.
The NHS will continue to use Palantir Foundry as part of its
COVID-19 response, including the planning and operational roll-out
of the UK’s vaccine programme.
Louis Mosley, Head of Palantir UK, said:
“Palantir is very proud to continue supporting the NHS, and this
contract underlines our deep commitment to the UK. We look forward
to supporting the NHS deliver its critical, life-saving work for
patients.”
Notes to Editors:
- NHS England’s announcement can be found here:
https://www.england.nhs.uk/blog/data-integration-driving-improvements-in-patient-care/
- The Contract can be found here:
https://www.contractsfinder.service.gov.uk/Notice/9233a767-bd2b-49eb-9c57-310bb2e259e0
About Palantir Technologies
Palantir Technologies is a software company that builds
enterprise data platforms for use by organizations with complex and
sensitive data environments. From building safer cars and planes,
to discovering new drugs and combating terrorism, Palantir helps
customers across the public, private, and nonprofit sectors
transform the way they use their data. Additional information is
available at https://www.palantir.com.
Forward-Looking Statements
This press release contains forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933, as
amended, and Section 21E of the Securities Exchange Act of 1934, as
amended. These statements may relate to, but are not limited to,
Palantir’s expectations regarding the amount and the terms of the
contract and the expected benefits of our software platforms.
Forward-looking statements are inherently subject to risks and
uncertainties, some of which cannot be predicted or quantified.
Forward-looking statements are based on information available at
the time those statements are made and were based on current
expectations as well as the beliefs and assumptions of management
as of that time with respect to future events. These statements are
subject to risks and uncertainties, many of which involve factors
or circumstances that are beyond our control. These risks and
uncertainties include our ability to meet the unique needs of our
customer; the failure of our platforms to satisfy our customer or
perform as desired; the availability of future government funding;
the frequency or severity of any software and implementation
errors; our platforms’ reliability; and our customer’s ability to
modify or terminate the contract. Additional information regarding
these and other risks and uncertainties is included in the filings
we make with the Securities and Exchange Commission from time to
time. Except as required by law, we do not undertake any obligation
to publicly update or revise any forward-looking statement, whether
as a result of new information, future developments, or
otherwise.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201223005019/en/
Lisa Gordon media@palantir.com
Palantir Technologies (NYSE:PLTR)
Historical Stock Chart
From Mar 2024 to Apr 2024
Palantir Technologies (NYSE:PLTR)
Historical Stock Chart
From Apr 2023 to Apr 2024